The Vitals | RSV Explained: Risks, Symptoms, and Prevention @MountSinaiNYC
The Vitals | RSV Explained: Risks, Symptoms, and Prevention  @MountSinaiNYC
Uploaded October 2025 | Updated November 2026, 3 hours ago
RSV (respiratory syncytial virus) isn’t new—but the conversation (and the tools) have changed. In this episode of The Vitals, host Leslie Schlachter sits down with Dr. Jennifer Duchon and Dr. Sean Liu to break down: how RSV spreads, why babies are at higher risk, what to watch for, why antibiotics don’t help, when oxygen is essential, and much more.

Learn more about our panelists:
Dr. Sean Liu: mshs.co/3WjBtsn
Dr. Jennifer Duchon: mshs.co/4nKWrMW

Explore Mount Sinai Podcasts: mshs.co/3VY4auw

00:00:24 — Introduction & Meet the Experts
Host Leslie Schlachter welcomes listeners and introduces Dr. Sean Liu and Dr. Jennifer Duchon. They discuss their backgrounds, specialties, and roles at Mount Sinai.

00:04:44 — RSV 101: What It Is & Why It Matters
The team explains what RSV (Respiratory Syncytial Virus) is, why it's gaining more attention, and its seasonal nature. Includes a discussion on how RSV compares to other common viruses like flu and COVID-19.

00:06:03 — RSV in Children: Symptoms, Risks & When to Seek Help
Focus on RSV in infants and young children — warning signs, how it progresses, and what parents should look out for. Covers breathing issues, feeding difficulties, and home monitoring tools like pulse oximeters.

00:11:04 — RSV in Adults: Vulnerabilities & Complications
How RSV affects older adults and those with chronic conditions. Includes hospitalization risks, symptom progression, and preventative measures like hygiene and masking.

00:15:27 — Treatment, Supportive Care & Clinical Trials
A deep dive into how RSV is treated (primarily supportive care), when hospitalization is necessary, and emerging antiviral treatments currently being studied in clinical trials at Mount Sinai.

00:21:59 — RSV Prevention: Monoclonal Antibodies & Pediatric Vaccination
Explains new preventative options like the monoclonal antibody nirsevimab (Beyfortus), rollout challenges, and effectiveness in reducing hospitalizations among infants.

00:25:30 — RSV Vaccines for Adults & Maternal Immunization
Overview of newly approved RSV vaccines for adults 60+ and pregnant women, including the science of antibody transfer to newborns.

00:27:34 — Clinical Trials & Misconceptions Around RSV Treatment
Details on current clinical trials for antiviral treatments and a discussion on common misconceptions around treating viral infections.

00:29:50 — Vaccines, Immune System Training & Public Health Messaging
Explores how vaccines "train" the immune system, the importance of seasonal boosters, and vaccine hesitancy concerns.

00:39:13 — Closing Reflections & Fun Segment: ‘Three Things I’d Never Do’
Wrap-up with a lighthearted list of infection-control habits from a neonatologist, plus a conversation on germs, commensal bacteria, and fungal apocalypse fiction.
The Vitals | RSV Explained: Risks, Symptoms, and Prevention2026 TRAIN Program Information SessionAsk the Doc: Overactive BladderThe Vitals | Winter Skin Deep頭頸癌放射治療 (H&N Traditional Chinese CC)HERology | Menopause, ReimaginedMount Sinai is the Official Health Care Partner of the US OpenLeveraging Your Wearables Health Data | Dr. Sanjai Sinha | Aspen Ideas Festival 2025Trailer: Advancing Our Commitment to Care With AIAdvancing Our Commitment to Care With AI: Realizing the Potential of GenomicsDr. Alexis Colvin: 15+ Years of Medicine at the US OpenBeyond the Badge - May 2, 2025
Mount Sinai Health System |

The Vitals | RSV Explained: Risks, Symptoms, and Prevention

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER